Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 32907820

14 results
Filters applied: . Clear all
Page 1
Active testing of groups at increased risk of acquiring SARS-CoV-2 in Canada: costs and human resource needs.
Campbell JR, Uppal A, Oxlade O, Fregonese F, Bastos ML, Lan Z, Law S, Oh CE, Russell WA, Sulis G, Winters N, Yanes-Lane M, Brisson M, Laszlo S, Evans TG, Menzies D. Campbell JR, et al. CMAJ. 2020 Sep 9:cmaj.201128. doi: 10.1503/cmaj.201128. Online ahead of print. CMAJ. 2020. PMID: 32907820
Seroprevalence of anti-SARS-CoV-2 antibodies in residents of Karachi-challenges in acquiring herd immunity for COVID 19.
Zaidi S, Rizwan F, Riaz Q, Siddiqui A, Khawaja S, Imam M, Naz A, Waheed S, Shamsi T. Zaidi S, et al. J Public Health (Oxf). 2020 Sep 17:fdaa170. doi: 10.1093/pubmed/fdaa170. Online ahead of print. J Public Health (Oxf). 2020. PMID: 32940328
Clinical Impact, Costs, and Cost-Effectiveness of Expanded SARS-CoV-2 Testing in Massachusetts.
Neilan AM, Losina E, Bangs AC, Flanagan C, Panella C, Eskibozkurt GE, Mohareb A, Hyle EP, Scott JA, Weinstein MC, Siedner MJ, Reddy KP, Harling G, Freedberg KA, Shebl FM, Kazemian P, Ciaranello AL. Neilan AM, et al. Clin Infect Dis. 2020 Sep 18:ciaa1418. doi: 10.1093/cid/ciaa1418. Online ahead of print. Clin Infect Dis. 2020. PMID: 32945845
Clinical Impact, Costs, and Cost-Effectiveness of Expanded SARS-CoV-2 Testing in Massachusetts.
Neilan AM, Losina E, Bangs AC, Flanagan C, Panella C, Eskibozkurt GE, Mohareb A, Hyle EP, Scott JA, Weinstein MC, Siedner MJ, Reddy KP, Harling G, Freedberg KA, Shebl FM, Kazemian P, Ciaranello AL. Neilan AM, et al. medRxiv. 2020 Jul 24:2020.07.23.20160820. doi: 10.1101/2020.07.23.20160820. Preprint. medRxiv. 2020. PMID: 32743604 Free PMC article. Updated.
Frequency of routine testing for SARS-CoV-2 to reduce transmission among workers.
Chin ET, Lo NC, Huynh BQ, Murrill M, Basu S. Chin ET, et al. medRxiv. 2020 May 6:2020.04.30.20087015. doi: 10.1101/2020.04.30.20087015. Preprint. medRxiv. 2020. PMID: 32511523 Free PMC article.
Evaluation and Comparison of the Hologic Aptima SARS-CoV-2 and the CDC 2019 nCoV real-time RT-PCR Diagnostic Panel using a Four-Sample Pooling Approach.
Mitchell SL, Ventura SE. Mitchell SL, et al. J Clin Microbiol. 2020 Sep 18:JCM.02241-20. doi: 10.1128/JCM.02241-20. Online ahead of print. J Clin Microbiol. 2020. PMID: 32948624
Decreasing High Risk Exposures for Healthcare-workers through Universal Masking and Universal SARS-CoV-2 Testing upon entry to a Tertiary Care Facility.
Walker J, Fleece ME, Griffin RL, Leal SM, Alsip JA, Stigler WS, Nafziger SD, Marrazzo JM, Lee RA. Walker J, et al. Clin Infect Dis. 2020 Sep 8:ciaa1358. doi: 10.1093/cid/ciaa1358. Online ahead of print. Clin Infect Dis. 2020. PMID: 32901247 Free PMC article.
Change in Antibodies to SARS-CoV-2 Over 60 Days Among Health Care Personnel in Nashville, Tennessee.
Patel MM, Thornburg NJ, Stubblefield WB, Talbot HK, Coughlin MM, Feldstein LR, Self WH. Patel MM, et al. JAMA. 2020 Sep 17. doi: 10.1001/jama.2020.18796. Online ahead of print. JAMA. 2020. PMID: 32940635 No abstract available.
Prevalence of SARS-CoV-2 Antibodies in Health Care Personnel in the New York City Area.
Moscola J, Sembajwe G, Jarrett M, Farber B, Chang T, McGinn T, Davidson KW; Northwell Health COVID-19 Research Consortium. Moscola J, et al. JAMA. 2020 Sep 1;324(9):893-895. doi: 10.1001/jama.2020.14765. JAMA. 2020. PMID: 32780804 Free PMC article.
Universal SARS-CoV-2 testing versus symptom based screening and testing in inpatient psychiatric setting.
Shahani L, Glazier S, Ostrosky L, Lane S, Soares JC. Shahani L, et al. Psychiatry Res. 2020 Sep 16;293:113444. doi: 10.1016/j.psychres.2020.113444. Online ahead of print. Psychiatry Res. 2020. PMID: 32971407 No abstract available.
14 results
Jump to page
Feedback